Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/oncolytics-biotech-announces-president-and-chief-executive-officer-dr-matt-coffey-to-take-medical-leave-of-absence-302180044.html
https://www.prnewswire.com/news-releases/from-comfort-to-cure-2024-asco-meeting-reveals-groundbreaking-oncology-data-302177108.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-asco-abstracts-highlight-pelareoreps-potential-in-pancreatic-cancer-and-immunotherapeutic-mechanism-of-action-302154957.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-announces-voting-results-from-the-annual-general-meeting-of-shareholders-302147378.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-initiates-enrollment-expansion-of-goblet-anal-cancer-cohort-302061219.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-appoints-patricia-s-andrews-to-its-board-of-directors-302029215.html
https://www.prnewswire.com/news-releases/oncolytics-announces-the-anal-cancer-cohort-of-the-goblet-phase-12-study-of-pelareorep-and-atezolizumab-has-met-the-success-criteria-for-efficacy-301983245.html
https://www.prnewswire.com/news-releases/oncolytics-biotech-and-solti-present-further-positive-pelareorep-translational-data-at-sitc-301977019.html
https://www.prnewswire.com/news-releases/oncolytics-presents-positive-updated-pancreatic-cancer-data-from-goblet-phase-12-study-at-esmo-301964264.html
https://www.prnewswire.com/news-releases/oncolytics-achieves-success-criteria-for-efficacy-in-the-third-line-colorectal-cancer-cohort-of-the-goblet-study-301964255.html